Home DailyMed 75fa5a9a-4166-4540-9e8e-623b41b15dd2 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:04:19
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N201277-001 GADAVIST GADOBUTROL 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 N201277-002 GADAVIST GADOBUTROL 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 N201277-003 GADAVIST GADOBUTROL 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 N201277-004 GADAVIST GADOBUTROL 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 N201277-005 GADAVIST GADOBUTROL 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 N201277-006 GADAVIST GADOBUTROL 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 258 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201277-005 GADAVIST 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N201277-006 GADAVIST 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18 84e616aacf4f…2026-08-18 06:07:40 2026-07 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201277-005 GADAVIST 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N201277-006 GADAVIST 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201277-005 GADAVIST 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N201277-006 GADAVIST 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201277-005 GADAVIST 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N201277-006 GADAVIST 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201277-005 GADAVIST 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N201277-006 GADAVIST 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201277-005 GADAVIST 39.3068GM/65ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N201277-006 GADAVIST 1.20944GM/2ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2013-12-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N201277-001 GADAVIST 4.5354GM/7.5ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N201277-002 GADAVIST 6.0472GM/10ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N201277-003 GADAVIST 9.0708GM/15ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N201277-004 GADAVIST 18.1416GM/30ML (604.72MG/ML) SOLUTION / INTRAVENOUS AP RLD, RS 2011-03-14 b8a1b40f171c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 148 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 74a2ff9319b5…2021-12-28 21:50 UTC 2021-12 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N201277-006 5980864 2021-11-09 U-1119 Drug substance, Drug product 2016-03-17 ea99ee380514…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 106 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.